Merck Slashes Its 2005 Estimates on Vioxx

"The withdrawal of painkiller Vioxx will reduce 2005 earnings of Merck & Co. Inc. to between $2.42 and $2.52 a share, below the already diminished expectations of Wall Street analysts, the huge drug maker said Wednesday." [Forbes.com]